Generix Group - Third Quarter Revenue 2020 / 2021: +2,4% at
constant exchange rates
FINANCIAL PRESS RELEASE
Paris, January 27, 2021
Revenue for Q3 2020/2021: +2,4% at constant exchange
rates
Q3 2020/2021 new SaaS contracts: +35%
Confirmation of financial objectives for
the fiscal period
Generix Group, a global provider of
collaborative SaaS Software solutions for the Supply Chain,
industrial, and retail ecosystems, issued today its revenues for
the third quarter of its 2020/2021 fiscal year.
Q3 revenue stable at current exchange rates (+2,4% at
constant exchange rates)
|
Quarter ended December 31 |
Change |
9 months ended December 31 |
Change |
Unaudited (K€) |
2020 |
2019 |
2020 |
2019 |
SaaS |
8 375 |
8 164 |
3% |
24 071 |
24 417 |
-1% |
Maintenance |
4 512 |
4 849 |
-7% |
13 489 |
14 514 |
-7% |
Licenses |
974 |
1 070 |
-9% |
2 834 |
2 800 |
1% |
Software revenues |
13 861 |
14 083 |
-2% |
40 394 |
41 731 |
-3% |
Consulting Services |
6 875 |
6 733 |
2% |
18 442 |
18 945 |
-3% |
Revenues |
20 736 |
20 816 |
0% |
58 836 |
60 676 |
-3% |
*Reclassification of €210K over the quarter and
€690K over 9 months, as Consulting and Services revenue, concerning
services previously accounted for as Maintenance revenue. After
reprocessing this reclassification, Maintenance revenue showed a
slight drop (-3% for Q3 and -2% in YTD), primarily as a result of
the temporary suspension of contracts during the lockdown period.
Consulting and Services revenue, which is by nature more vulnerable
in the current context, showed a -1% slight drop over Q3 and a -6%
drop in YTD.
During this quarter, at the heart of the second
wave of Covid-19 and the associated government restrictions
(lockdown, curfew), Generix Group's activity amounted to €20.7
million, almost stable compared to the same period last year and up
8.1% compared to Q2 2020/2021. Quarter after quarter, Generix Group
illustrates the resilience of its model and confirms the trajectory
of a return to normative growth levels. At constant exchange rates,
quarterly revenues amounted to €21.3 million, up 2.4% compared with
the same quarter last year.
This quarter also marks the return to revenue
growth in SaaS activities, which grew by +3% at current exchange
rates, thanks to a significant improvement in overconsumption
compared with previous quarters.
Over 9 months, Group revenues were €58.8 million
(-3%) at current exchange rates, and €60 million, a slight decrease
of 1% at constant exchange rates.
Q3 new SaaS contracts: €1,35 million (+35%)
|
Quarter ended December 31 |
Var. Q3 2020 vs Q3 2019 |
9 months ended December 31 |
Var. 2020 vs 2019 |
Unaudited (K€) |
2020 |
2019 |
2020 |
2019 |
New SaaS contract signing (ACV*) |
1 349 |
1 002 |
35% |
2 530 |
2 361 |
7% |
*New contracts signed expressed in ACV (Annual
Contract Value), emphasize the average annual complementary revenue
to be generated after implementing the contracts in question.
In addition to the resumption of growth in the
SaaS business, the past quarter was also marked by a return to a
sustained pace of new SaaS contract signatures, with strong growth
of 35% over the quarter. This commercial dynamic has largely offset
the temporary drop in signatures in the first half year: overall,
SaaS signatures are up 7% over 9 months.
Among these new signatures, it should be
noted:
- A migration contract for a major player in
specialized retail, which has chosen to switch the management of
its warehouses and transport from a perpetual license model (On
Premise) to a SaaS model;
- A contract with a new customer on the Iberian
Peninsula, a banking player that has chosen the Generix Supply
Chain Hub platform to manage its exchange flows and the
dematerialization of its invoices.
These contracts confirm Generix Group's ability
to respond to strategic customer needs and win the trust of major
players.
Confirmation of financial objectives for
the fiscal period
Generix Group anticipates a sustained pace of
new SaaS contract signings over the coming quarters, which should
enable a return to normative growth as of the 2021/2022 financial
year, after a slight decline in the 2020/2021 financial year.
Profitability trends for the 2020/2021 financial
year should be in line with those observed in the first half year,
with a controlled decline in EBITDA margin excluding the impact of
the research and development effort.
With a sound and solid financial structure, a
resilient business model, and a robust customer portfolio, the
Group is confident for the future. As announced, it intends to
continue its strategic investments in R&D to benefit from the
potential of the supply chain and digitalization markets in which
it already operates successfully.
Supplemental
and non-IFRS Financial Information
Supplemental non-IFRS
information (above-mentioned as EBITDA) presented in this press
release is subject to inherent limitations. It is not based on any
comprehensive set of accounting rules or principles and should not
be considered as a substitute for IFRS measurements. Also, the
Company’s supplemental non-IFRS financial information may not be
comparable to similarly titled non-IFRS measures used by other
companies.
Next financial press release: April 28, 2021
after the market closes
Revenues for the financial year 2020/2021
About Generix Group
Generix Group is a
Collaborative Supply Chain expert present in 60 countries, thanks
to its subsidiaries and network of partners. More than 6,000
companies around the world use its SaaS solutions. The group’s 750
employees provide daily support for such customers as Carrefour,
Danone, FM Logistic, Fnac-Darty, Essilor, Ferrero and Geodis in the
digital transformation of their Supply Chain.
Its collaborative platform, Generix
Supply Chain Hub, helps companies to keep the promises
they make to their customers. It combines the capabilities to
execute physical flows, digitalize information flows, manage
collaborative processes and connect companies to all their
partners, in real time.
Generix Supply Chain Hub is
aimed at all players in the Supply Chain: manufacturers, third- and
fourth-party logistics providers (3PL/4PL) and retailers.
www.generixgroup.com
Founded in France in 1990, the company is listed on
the Eurolist market of Euronext Paris, compartment C (ISIN:
FR0010501692). To learn more: www.generixgroup.com
Financial Communication Contacts: Generix
Group—Ludovic Luzza—Chief Financial Officer—Tel.: +33 (0)1 77
45 42 80 – lluzza@generixgroup.comCIC Market
Solutions—Stéphanie Stahr—Tel.: +33 (0)1 53 48 80
57—stephanie.stahr@cic.fr
- EXT-EN-FINA-PR-REV-Q3-2020-2021